← Leaderboards
Ricardo Anibal Maselli
University Of California At Davis
$2,447,218
Attributed
$3,097,840
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $601K · FY2010–25$1M$750K$500K$250K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,097,840 · 3
By mechanism
R01$1,636,845 · 1
R42$1,301,245 · 1
R03$159,750 · 1
Top collaborators
- Patricio Sepulveda3 shared
Most similar at University Of California At Davis
Same institution · by research overlap
- David P Richman$641,851
Others in their field
Top investigators on “Animal Model”
- David Heimbrook · Leidos Biomedical Research, Inc.$464,525,875
- Dennis R. Burton · Scripps Research Institute$204,129,233
- Joseph E Robertson · Oregon Health & Science University$126,125,279
- Peter Gordon Gillespie · Oregon Health And Science University$105,808,119
- David M Anderson · University Of Washington$102,920,737
- Polly Chang · Sri International$84,271,267
Research focus
Animal ModelCongenital Myasthenic SyndromesMuscleAdultResponseAffectPhenotypeProteinsNeuromuscular DiseasesMuscle WeaknessNeuromuscular JunctionAcetylcholinesteraseTransmission ProcessMutationLeadDefectNeuromuscular TransmissionCollagenInheritedMutateLifeBiologicalGenesImmunohistochemistry
Grant awards (9)
Targeted ColQ gene therapy for Congenital Myasthenic Syndromes$601,044
R42 · FY2025 · NS
Targeted ColQ gene therapy for Congenital Myasthenic Syndromes$207,090
R42 · FY2024 · NS
Targeted ColQ gene therapy for Congenital Myasthenic Syndromes$493,111
R42 · FY2023 · NS
Engineering of a mouse model of choline acetycholinesterase deficients using CRISPR/Cas9 gene editing$159,750
R03 · FY2022 · NS · contact PI
Congenital Myasthenic Syndromes: Pathogenic Mechanisms$325,775
R01 · FY2014 · NS · contact PI
Congenital Myasthenic Syndromes: Pathogenic Mechanisms$317,893
R01 · FY2013 · NS · contact PI
Congenital Myasthenic Syndromes: Pathogenic Mechanisms$329,781
R01 · FY2012 · NS · contact PI
Congenital Myasthenic Syndromes: Pathogenic Mechanisms$328,708
R01 · FY2011 · NS · contact PI
Congenital Myasthenic Syndromes: Pathogenic Mechanisms$334,688
R01 · FY2010 · NS · contact PI